Dr. Loui Abdelghani, MD

Dr. Abdelghani practices at Memorial Medical Center in Modesto, California, part of Sutter Health.

Dr. Abdelghani's NPI, 1912161787, was assigned on July 11, 2008. Dr. Abdelghani graduated from Jordan University of Science and Technology FOM in 2002. Dr. Abdelghani holds Florida license ME128546.

Dr. Abdelghani's primary practice is Memorial Medical Center, at 1700 Coffee Rd, Modesto, CA 95355 in Stanislaus County. The practice phone is (209) 526-4500.

Dr. Abdelghani's primary practice is Memorial Medical Center in Modesto, California, part of Sutter Health. Dr. Abdelghani is also affiliated with Dignity Health - St. Joseph's Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Abdelghani to 3 more hospitals, 6 medical groups, 4 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelghani practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Abdelghani's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Abdelghani is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abdelghani's licenses on file in 9 states: Florida, California, Illinois, Texas, Ohio, West Virginia, Kentucky, Missouri and Iowa.

Dmand AI lists asthma, atrial fibrillation and flutter, chronic hypertension, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, coronary artery disease, heart failure and heart valve disorders among the conditions Dr. Abdelghani treats.

CMS data shows 1,174 Medicare services from Dr. Abdelghani across 8 procedure codes in 2024, for 528 Medicare patients. Medicare paid $150,224 for them.

CMS counts 528 Medicare patients who saw Dr. Abdelghani in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelghani's median patient age at 66, with 48% women.

In 2024, Dr. Abdelghani wrote 332 Medicare Part D claims for 99 patients. 36% of them were for generic drugs. CMS names the drug for 195 of them, across 6 drugs with 11 or more claims each, at $99,655 in total drug cost. In 2023, CMS named 329 claims across 13 drugs.

Dr. Abdelghani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Abdelghani, published from 2019 to 2024. 2024 was the busiest year, with 2. Dr. Abdelghani has published most often in Cureus. Dr. Abdelghani's most frequent co-authors are Jay Blong Lue Xiong, DO, Edsel Embry, MD and Aamir Javaid, MD.

CMS Open Payments shows 110 general payments to Dr. Abdelghani from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $285.

Dr. Abdelghani graduated from Jordan University of Science and Technology FOM in 2002.

Dr. Abdelghani is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.